ArticleAngewandte Chemie (International ed. in English)2022

Boosting Bismuth(III) Complexation for Targeted α-Therapy (TAT) Applications with the Mesocyclic Chelating Agent AAZTA.

Dávid Horváth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.